Search

Your search keyword '"Srimuninnimit V"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Srimuninnimit V" Remove constraint Author: "Srimuninnimit V" Publisher elsevier ltd Remove constraint Publisher: elsevier ltd
14 results on '"Srimuninnimit V"'

Search Results

3. O-015 Association between depth of response (DpR) and survival outcomes in RAS-wild-type (wt) patients with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab once-every-2-weeks in the APEC study

4. Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial

8. “Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC”

11. 244PD - Everolimus (EVE) + letrozole (LET) in patients (pts) with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4

Catalog

Books, media, physical & digital resources